Archive

2005 – 2012

  |  

Barry begins his research in cardiovascular biomechanics, working alongside clinicians, medical imaging experts, scientists and engineers in Ireland, Scotland and internationally. Early prototype computer models are developed across a range of cardiovascular diseases, laying the foundation for future work....

Read More

2025

  |  

Mosaic V1 receives clearance by the FDA marking a major milestone for the company! Additional non-dilutive funding awarded by the WA Government. Further product development efforts start to accelerate as the company expands its portfolio....

Read More

2024

  |  

Navier is accepted into the prestigious ANDHealth+ Grow program, establishes a world-class Advisory Board, and makes huge progress on the product development of Mosaic V1, submitting the 510(k) application on Christmas Day!...

Read More

2023

  |  

Navier moves into a new HQ and begins to build its culture while also progressing with technical development and marketing approvals of its first product, Mosaic....

Read More

2022

  |  

Otto joins the company as Executive Chairman, Sander commences as CEO and Barry moves to an Adjunct position at UWA and becomes CTO. Navier Medical is awarded the ‘Most Outstanding Patient Innovation’ by the Australian Patients Association....

Read More

2021

  |  

Barry starts Navier Medical Limited as the company spins out of the UWA and the Harry Perkins Institute of Medical Research, with Lachlan joining as employee #1. Otto Buttula takes a stake in the company, and Barry connects with Sander Bangma. Jonathan Tapley joins the...

Read More

2020

  |  

A voice of customer study is performed with Curve Tomorrow and further de-risking is performed through ANDHealth workshops....

Read More

2019

  |  

Lachlan completes his PhD and UWA commences the spin-out process. De-risking activities are performed with the product development company Planet Innovation....

Read More

2018

  |  

Project results are encouraging and efforts begin to commercialize software technology, with help from Dr Sam South at UWA....

Read More

2014

  |  

Collaboration begins with Prof Carl Schultz, a cardiologist at UWA and the Royal Perth Hospital, on coronary artery disease. Lachlan Kelsey begins his PhD on the project....

Read More